UBS’s Exact Sciences EXAS Stock Holding History

UBS’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2.71M	Sell	139,795 -7,087	-5%	-$130K	﹤0.01%	2620
2014 Q2	$2.5M	Sell	146,882 -14,585	-9%	-$201K	﹤0.01%	2667
2014 Q1	$2.29M	Buy	161,467 +31,666	+24%	+$428K	﹤0.01%	2646
2013 Q4	$1.52M	Buy	129,801 +32,733	+34%	+$376K	﹤0.01%	3088
2013 Q3	$1.15M	Buy	97,068 +8,493	+10%	+$109K	﹤0.01%	3190
2013 Q2	$1.23M	Buy	+88,575	New	+$962K	﹤0.01%	3097

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

UBS's EXAS Position: Q3 2014 in Review

UBS reduced its Exact Sciences (EXAS) stake by 4.8% in Q3 2014, selling an estimated $130K and leaving 139,795 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

UBS first reported a position in EXAS in Q2 2013 and has held it in 6 quarters since. 175 funds tracked by Wall St. Rank hold EXAS as of Q3 2014.

UBS held 139,795 shares of Exact Sciences worth $2.71M as of Q3 2014.
UBS sold 7,087 Exact Sciences shares in Q3 2014, an estimated $130K.
Exact Sciences made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2620 holding.
UBS first reported a position in Exact Sciences in Q2 2013 and has held it in 6 quarters since.
175 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.